NeuroMetrix Selected By Fortune Small Business

Cambridge, MA (April 28, 2000) - The May/June issue of Fortune Small Business (FSB) was released this week and NeuroMetrix, Inc. (Cambridge, MA) learned that it has been selected as one of the "FSB 25" in their annual survey of companies with breakthrough products or services.

Fortune Small Business surveys hundreds of companies, incubators and research labs to identify innovators and companies that can have "an explosive impact on its industry niche". FSB recognized founder and CEO Shai Gozani, MD, PhD for the development of NC-Stat™, a handheld device that helps clinicians evaluate patients with neuromuscular conditions, such as carpal tunnel syndrome. The article went on to point out that the product is compact, easy to use and is being used in a number of Fortune 500 Companies.

"We are honored to be selected by Fortune Small Business," said Dr. Gozani. "It is wonderful recognition for the outstanding NeuroMetrix team that brought NC-stat to market. We share FSB's vision that this product will dramatically improve the diagnosis and management of common neuromuscular diseases in the primary care setting."

The NC-stat nerve conduction monitoring system has been designed for convenient, point-of-care evaluation of median nerve neuropathies, such as carpal tunnel syndrome. The product consists of a hand-held monitor, a disposable biosensor and an information management system that generates a highly informative report.

NeuroMetrix, Inc., a development stage company located in Cambridge, MA is a spin-off from the Harvard-M.I.T. Division of Health Sciences and Technology. Based on advances in neuroscience and microelectronics, NeuroMetrix is developing a new class of non-invasive products for point-of-care testing for neuromuscular disorders. The Company anticipates that its technology will provide physicians with immediate and cost-effective information to be used as an aid in the diagnosis of common neuromuscular conditions including repetitive stress injuries, peripheral and toxic neuropathies and low back pain.

For more information about NeuroMetrix, Inc., call 1-888-786-7287 or visit the company's web site at http://www.neurometrix.com

Contact: Richard J. Thomas, President